Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>iFabric’s Intelligent Fabrics division is seeing explosive growth, led by its antibacterial and antimicrobial medical scrubs.</li>
<li>Management recently guided for 267% YoY revenue growth in Q1.</li>
<li>The Company has seen a strong expansion of its distribution network in both big-box retailers and wholesale clubs in North America.</li>
</ul>


iFabric’s Intelligent Fabrics division is seeing explosive growth, led by its antibacterial and antimicrobial medical scrubs.
Management recently guided for 267% YoY revenue growth in Q1.
The Company has seen a strong expansion of its distribution network in both big-box retailers and wholesale clubs in North America.


IFA：爆発的な収益成長は、医療用スクラブ市場の複数年にわたる成長余地を示唆